Advertisement

Topics

Search Results for "Transvaginal Mesh Lawsuits Latest News"

07:56 EST 13th February 2016 | BioPortfolio

Matching Channels

Facebook - BioPortfolio Pages

BioPortfolio has launched a number of Facebook pages to allow our visitors to keep track with latest news, published paper and clinical trials by lead biotechnology and healthcare topics:- &nbs...

Contract Research Organization news

A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form o...

Siemens

Siemens Healthcare is the second largest medical devices company in the world (based on annual sales), with sales of $17.4 billion. Specializing in the imaging, IT, diagnostics and workflow soluti...

Clinical Trials Phase News

Clinical trials involving new drugs are commonly classified into four phases. Each phase of the drug approval process is treated as a separate clinical trial. The drug-development process will norma...

Antibody classes

An antibody, also known as an immunoglobulin, is a large Y-shaped protein used by the immune system to identify and neutralize foreign objects such as bacteria and viruses. The antibody recognizes a...

Matching News

C.R. Bard Settles 3,000 Mesh Cases for $200 Million

Victims of transvaginal mesh injuries earned another victory over device manufacturers. C.R. Bard agreed to pay $200 million to settle roughly 3,000 cases, concluding about 20 percent of remaining law...

J&J Agrees to Pay Over $120M to Settle Thousands of Mesh Lawsuits

Johnson & Johnson offered a large settlement to resolve its first big group of transvaginal mesh lawsuits, Bloomberg reported. The company agreed to settle as many as 3,000 cases for more than $12...

J&J Takes $12.5 M Hit in Philly Transvaginal Mesh Trial

Johnson & Johnson’s Ethicon unit took a multi-million dollar trial loss over its transvaginal mesh implant at the end of last year, and 2016 started off with the Food and Drug Administration...

C.R. Bard Pays $3.6MM in First Avaulta Transvaginal Mesh Case

HOUSTON, Nov. 18, 2015 /PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company which operates http://www.lawsuitsettlementnews.com/, announced today that C.R. Bard finally pa...

FDA Reclassifies Vaginal Mesh as a High-Risk Device

Already hounded by numerous lawsuits over adverse events, manufacturers have 30 months to prove the safety and effectiveness of these devices for transvaginal repair of pelvic organ prolapse. News ...

Boston Scientific mesh verdict slashed to $10 million

NEW YORK (Reuters) - A Delaware judge on Friday said Boston Scientific should only have to pay $10 million to a woman originally awarded $100 million by a jury who found she was injured by transvagina...

Transvaginal Mesh Lawsuit Settlement News: Coloplast Increases TVM Budget by $448MM

HOUSTON, Nov. 5, 2015 /PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that Coloplast has recently increased ...

Ethicon Gets Hit with $12.5MM Jury Verdict in Transvaginal Mesh Case

PHILADELPHIA, Jan. 12, 2016 /PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that in the latest transvag...

Matching PubMed Articles

Transvaginal mesh in the media following the 2011 US food and drug administration public health notification update.

Prompted by patients' changing perceptions of transvaginal mesh, this study examines how mesh has been reported in the news following the 2011 US Food and Drug Administration (FDA) updated notificatio...

Management of complications of mesh surgery.

Transvaginal placements of synthetic mid-urethral slings and vaginal meshes have largely superseded traditional tissue repairs in the current era because of presumed efficacy and ease of implant with ...

3-year results of transvaginal cystocele repair with transobturator four-arm mesh: A prospective study of 105 patients.

To evaluate the long-term efficacy and safety of transobturator four-arm mesh for treating cystoceles.

News in brief.

A roundup of the latest nursing news.

News in brief.

A roundup of the latest nursing news.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement